Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
+889K
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$20.5M
-
Put/Call ratio
-
0.67
-
Number of buys
-
117
-
Number of sells
-
-108
-
Price
-
$11.26
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2025
272 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q2 2025.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.9M shares), CADIAN CAPITAL MANAGEMENT, LP (10.4M shares), BlackRock, Inc. (9.38M shares), MORGAN STANLEY (8.05M shares), Durable Capital Partners LP (6.42M shares), FMR LLC (6.42M shares), Engaged Capital LLC (5.85M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (4.32M shares), EVENTIDE ASSET MANAGEMENT, LLC (4.09M shares), and GOLDMAN SACHS GROUP INC (3.1M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.